ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Douma, W.
Right arrow Articles by Postma, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Douma, W.
Right arrow Articles by Postma, D.
Eur Respir J 1998; 12: 848-852
Copyright © ERS Journals Ltd 1998


Clinical Trial

Risk of overtreatment with current peak flow criteria in self-management plans. Dutch CNSLD Study Group. Chronic Non-Specific Lung Disease

WR Douma, HA Kerstjens, JM Rooyackers, GH Koeter, and DS Postma

Home peak expiratory flow (PEF) measurements have become the cornerstone of asthma self-management plans. However, the cut-off values for changing treatment have not been formally tested. This study focusses on the possible overtreatment brought about by the different cut-off values and denominators currently employed. Data from 133 clinically stable asthmatic patients from a 2.5 yr follow-up study were analysed. The results showed that strict adherence to current criteria would lead to severe overtreatment, with up to 30% of clinically stable patients crossing into the lowest (red) zone at least once a year when personal best is the denominator and when it has not been limited to a defined time of day or to defined prior bronchodilator use. As expected, the passage of clinically stable patients into the lower zones became less frequent when cut-off values were sharpened and when time- and treatment-specific PEFs were used as the denominators. Strict adherence to commonly used peak expiratory flow cut-off values would lead to considerable overtreatment. In order to avoid overtreatment, the morning peak expiratory flow before any (bronchodilator) treatment should be related to the personal best peak expiratory flow measured under the same conditions. The choice of the right cut-off value will also depend on studies being performed to test the amount of undertreatment with a given value.


This article has been cited by other articles:


Home page
Mayo Clin Proc.Home page
B. Thorsteinsdottir, G. W. Volcheck, B. E. Madsen, A. M. Patel, J. T. C. Li, and K. G. Lim
The ABCs of Asthma Control
Mayo Clin. Proc., July 1, 2008; 83(7): 814 - 820.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. Wensley and M. Silverman
Peak Flow Monitoring for Guided Self-management in Childhood Asthma: A Randomized Controlled Trial
Am. J. Respir. Crit. Care Med., September 15, 2004; 170(6): 606 - 612.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
V Brusasco
Usefulness of peak expiratory flow measurements: is it just a matter of instrument accuracy?
Thorax, May 1, 2003; 58(5): 375 - 376.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the European Respiratory Society.